Exposure to Maternal Diabetes during Pregnancy Is Associated with Aggravated Short-Term Neonatal and Neurological

Nancy Laval1,2, Mariane Paquette1,2, Hamza Talsmat1

  • 1CHU Ste-Justine Research Center, Montréal, QC, Canada.

Insights

Maternal diabetes in infants with hypoxic-ischemic encephalopathy (HIE) is linked to worse outcomes, including longer hospital stays and increased risk of death or abnormal neurological exams. Managing maternal diabetes is crucial for improving neonatal HIE prognosis.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Neurology

Background:

  • Infants of diabetic mothers (IDM) face higher risks of perinatal complications.
  • The specific impact of maternal diabetes on neonatal hypoxic-ischemic encephalopathy (HIE) outcomes is not well-defined.

Purpose of the Study:

  • To investigate the effect of maternal diabetes on short-term neonatal and neurological outcomes in infants diagnosed with HIE.

Main Methods:

  • Retrospective single-center study of 102 neonates with HIE treated with therapeutic hypothermia (2013-2020).
  • Multiple regression analysis was employed to evaluate the association between maternal diabetes and neonatal outcomes.

Main Results:

  • Neonates exposed to maternal diabetes had lower gestational age and higher birth weight.
  • Infants of diabetic mothers with HIE required longer ventilation, had extended NICU stays, and took longer to achieve full oral feeds.
  • Maternal diabetes was associated with a significantly increased risk of death or abnormal neurological examination at discharge (OR: 6.41).

Conclusions:

  • Maternal diabetes is linked to increased risks of death and short-term morbidities in neonates with HIE.
  • These morbidities include prolonged ventilation, extended neonatal intensive care unit stays, and abnormal neurological findings at discharge.
  • Prioritizing strategies to prevent and manage maternal diabetes during pregnancy is essential for mitigating HIE complications.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K